Report on a new Klotho-focused longevity residency that combined expert talks, clinical interventions, and biomarker monitoring for attendees.
Key Takeaways
- Inaugural residency included 22 attendees and ran over multiple days
- Attendees received an intravenous Klotho therapy delivered via a lipid nanoparticle platform
- Pre and post serum samples were collected to assess individualized biomarker changes